Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dabrowski

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Der Radiologe|January 23, 2015
[Systemic treatment of distant metastatic malignant melanoma]E Dabrowski, E Dippel
Journal of Virology|June 1, 1991
Herpes simplex virus type 1 origin-specific binding protein: oriS-binding properties and effects of cellular proteinsC E Dabrowski, P A Schaffer
Journal of Virology|July 1, 1994
Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPCK Baradaran, C E Dabrowski, P A Schaffer
Molecular and Cellular Biology|April 1, 1994
Cellular protein interactions with herpes simplex virus type 1 oriSC E Dabrowski, P J Carmillo, P A Schaffer
Pediatric Neurology|September 1, 1989
Childhood lumbosacral plexus neuropathyG I Awerbuch, M A Nigro, E Dabrowski, et al.
Journal of Virology|August 1, 1996
Properties of the novel herpes simplex virus type 1 origin binding protein, OBPCK Baradaran, M A Hardwicke, C E Dabrowski, et al.
Bone|May 6, 2014
Bone mineral density changes following discontinuation of ronacaleret treatment: off-treatment extension of a randomized, dose-finding phase II trialLorraine A Fitzpatrick, Margaret Wooddell, Christine E Dabrowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2011
Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal womenLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral densityLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
Bone|July 12, 2011
Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trialLorraine A Fitzpatrick, Phillipa L Smith, Trish A McBride, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Der Radiologe|January 23, 2015
[Systemic treatment of distant metastatic malignant melanoma]E Dabrowski, E Dippel
Journal of Virology|June 1, 1991
Herpes simplex virus type 1 origin-specific binding protein: oriS-binding properties and effects of cellular proteinsC E Dabrowski, P A Schaffer
Journal of Virology|July 1, 1994
Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPCK Baradaran, C E Dabrowski, P A Schaffer
Molecular and Cellular Biology|April 1, 1994
Cellular protein interactions with herpes simplex virus type 1 oriSC E Dabrowski, P J Carmillo, P A Schaffer
Pediatric Neurology|September 1, 1989
Childhood lumbosacral plexus neuropathyG I Awerbuch, M A Nigro, E Dabrowski, et al.
Journal of Virology|August 1, 1996
Properties of the novel herpes simplex virus type 1 origin binding protein, OBPCK Baradaran, M A Hardwicke, C E Dabrowski, et al.
Bone|May 6, 2014
Bone mineral density changes following discontinuation of ronacaleret treatment: off-treatment extension of a randomized, dose-finding phase II trialLorraine A Fitzpatrick, Margaret Wooddell, Christine E Dabrowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2011
Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal womenLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral densityLorraine A Fitzpatrick, Christine E Dabrowski, Gregory Cicconetti, et al.
Bone|July 12, 2011
Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trialLorraine A Fitzpatrick, Phillipa L Smith, Trish A McBride, et al.
Pageof 2